Haleon plc (HLN) Stock Profile & Financial OverviewHaleon plc
HLN Company Overview & Business Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Key Information
Current Trend for HLN
An assessment of the current trend environment for HLN, based on the latest closing price data and intended to describe the market context heading into the next trading session.
As of 2025-12-24, the current trend for HLN is an Indeterminate Transition Phase (Unclear Direction).
Daily and weekly trends are conflicting, reducing directional conviction and making directional trading less favorable at this stage.
- Weekly trend signals are neutral, offering limited directional guidance for the higher timeframe.
- Price is currently significantly overextended (stretched), sitting 3.28 ATR away from the adaptive KAMA baseline.
- Technical Update: Price has breached a key Fractal High, confirming a structural breakout to the upside.
Explore More Data
Adaptive Trend Model · Daily & Weekly (2025-12-24 ET)
This model uses an adaptive trend algorithm based on daily and weekly price data to identify whether a stock is in an uptrend, downtrend, or consolidation over a multi-week to multi-month horizon. Compared with traditional moving-average systems, it filters short-term noise more effectively, captures trend continuation more reliably, and provides a stronger basis for position sizing and risk-management decisions such as stop-loss and take-profit levels.
As of 2025-12-24, HLN in a strong expansion phase; Long-term trend is bearish.
Trend Strength: HLN last closed at 10.10, trading 1.3 ATR above the adaptive KAMA baseline (9.90). Technical Classification: Confirmed High-Momentum Uptrend.
Trend Score: Technical Score: 70/100. Classification: Strong/Established. Alignment: Moderate. Logic: Positive directional bias confirmed by slope but remains in a developing phase.
SuperTrend Risk: Structural Support: Adaptive SuperTrend at 9.32. This level serves as the calculated invalidation point for the current upward structure.
Risk Skew: Multi-timeframe risk skew is currently assessed as Conflicted / Counter-Trend. Daily action is trending up, but faces a bearish weekly backdrop. This creates a high-risk 'bull trap' environment where upside may be capped by macro resistance.
Key Levels: In this bullish structure, key support is anchored by immediate support (KAMA) at 9.90, with the critical trend-guard (SuperTrend) at 9.32.